Has Matthew Bautel received payments from drug or device companies?

Yes. Drug and device makers reported $5,310 in general payments to Matthew Bautel across 262 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Bautel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Bautel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Bautel

Family · Clarkston, MINPI 1245951870

Payments from drug & device makers

$5,310in general payments, 2019–2025

Across 262 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$629
Otsuka America Pharmaceutical, Inc.$582
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$493
Teva Pharmaceuticals USA, Inc.$362
Johnson & Johnson$362
Axsome Therapeutics, Inc.$359
plus $3K from 15 others

What the payments were for

Food & beverage$5,25499%
Education$561%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	27	$629
Otsuka America Pharmaceutical, Inc.	44	$582
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	25	$493
Teva Pharmaceuticals USA, Inc.	15	$362
Johnson & Johnson	5	$362
Axsome Therapeutics, Inc.	7	$359
Neurocrine Biosciences, Inc.	14	$338
Vanda Pharmaceuticals Inc.	14	$324
Supernus Pharmaceuticals, Inc.	20	$300
Almatica Pharma LLC	16	$296
Alkermes, Inc.	14	$293
Corium, LLC	23	$272
Lundbeck LLC	10	$180
Ironshore Pharmaceuticals Inc.	8	$156
Collegium Pharmaceutical, Inc.	4	$68
Noven Therapeutics, LLC	3	$58
E.r. Squibb & Sons, L.L.C.	3	$55
Indivior Inc.	2	$51
Luye Pharma (USA) Ltd.	3	$48
Takeda Pharmaceuticals U.S.A., Inc.	3	$46
Tempus AI, Inc	2	$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,310 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Duloxetine Hcl	13	$800
Venlafaxine Hcl ErVenlafaxine Hcl	13	$625
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	26	$616
Trazodone Hcl	23	$243
Buspirone Hcl	22	$203
Quetiapine Fumarate	18	$197
Zolpidem Tartrate	12	$76

Paid to pharmacies, not to this prescriber.

Other family in Clarkston

Jayme HeimGrandville$663K
Susan WolgamottBloomfield Township$327K
Elisheva EllenbergDetroit$150K
Sarah JohnsonFarmington Hills$119K
Daniela MaximTroy$112K
Kelsey PrinceGrand Rapids$87K
Brent MillerFremont$66K
Rachael CompeauFlint$62K
David KocendaLapeer$49K
Tracy RobertsonBay City$47K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →